Cosmetic Surgery Market Poised to Reach USD 186.5 Billion by 2033 | Surging Prevalence of Aesthetic Procedures Drives Industry Growth
01 févr. 2024 07h45 HE
|
Market.Us
New York, Feb. 01, 2024 (GLOBE NEWSWIRE) -- According to Market.us, the global Cosmetic Surgery Market size is forecasted to exceed USD 186.5 Billion by 2033, with a promising CAGR of 5.1% from 2024...
Biofrontera AG: Receives reasons from the Federal Court of Justice for overturning ruling of the Cologne Higher Regional Court
14 oct. 2020 04h30 HE
|
Biofrontera AG
Leverkusen, Germany, Oct. 14, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, had announced on...
Admission to trading of Biofrontera’s 1.00% qualified subordinated mandatory convertible bond 2020/2021
20 août 2020 13h00 HE
|
Biofrontera AG
Leverkusen, Germany, Aug. 20, 2020 (GLOBE NEWSWIRE) -- On August 18, 2020, Biofrontera AG (shares of Biofrontera AG ISIN: DE 00 6046113) announced the successful placement of the 1.00% qualified...
Capital measure oversubscribed: Placement of the 1.00 % qualified subordinated mandatory convertible bond 2020/2021
18 août 2020 05h00 HE
|
Biofrontera AG
Leverkusen, Germany, Aug. 18, 2020 (GLOBE NEWSWIRE) -- In a press release dated July 27, 2020, Biofrontera AG (shares of Biofrontera AG ISIN: DE0006046113) announced the issuance of up to 2,638,150...
Supervisory Board of Biofrontera AG renews Management Board appointment
23 juil. 2020 08h30 HE
|
Biofrontera AG
Leverkusen, Germany, July 23, 2020 (GLOBE NEWSWIRE) -- The Supervisory Board of Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F), an international biopharmaceutical company, today...
Biofrontera confirms financing need
30 juin 2020 08h30 HE
|
Biofrontera AG
Leverkusen, Germany, June 30, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today confirmed the...
Biofrontera announces conference call to be held on April 21, 2020 to discuss full year 2019 financial results
09 avr. 2020 12h30 HE
|
Biofrontera AG
Leverkusen, Germany, April 09, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be releasing...
Biofrontera reports preliminary unaudited sales revenue for the first nine months of 2019
10 oct. 2019 05h15 HE
|
Biofrontera AG
Leverkusen, Germany, Oct. 10, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company” or the “Biofrontera-group”), an international biopharmaceutical...
Results of the voluntary partial tender offers
24 juil. 2019 06h30 HE
|
Biofrontera AG
Leverkusen, Germany, July 24, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, informs about the...
Annual General Meeting of Biofrontera AG: Biofrontera Management Board approved by large majority
11 juil. 2019 05h23 HE
|
Biofrontera AG
Leverkusen, Germany, July 11, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced the...